Atul Limited (Atul) reported consolidated revenue of Rs. 1,002 crore (down 4.2%; up 51.7% q-o-q), which was 7.9% above our estimate of Rs. 929 crore. Revenue beat was on the account of betterthan-expected revenue from life science chemicals segment at Rs. 348 crore (up 5.3% y-o-y; up 28.3% q-o-q), while revenue from performance and other chemicals segment was largely in-line at Rs. 690 crore (down 7.7% y-o-y; up 64% q-o-q). The sharp sequential improvement in revenue can be attributed to higher demand from key user industries in the domestic market as economic activities recovered sharply post unlockdown by the government. EBITDA margin came in at 26.1% (up 460 bps y-o-y; up 204 bps q-o-q), which was also above our estimate of 25% due to higherthan-expected margin in the performance and other chemicals segment (EBIT margin up 411 bps y-o-y to 23.1%). The improvement in EBITDA margin was on account of better operating leverage...